TELA Bio, Inc. (TELA)
0.965
-0.04
(-4.46%)
USD |
NASDAQ |
Oct 23, 16:00
0.9907
+0.03
(+2.66%)
After-Hours: 20:00
TELA Bio EPS Diluted (Quarterly) : -0.1962 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1962 |
| March 31, 2026 | -0.2144 |
| December 31, 2025 | -0.1749 |
| September 30, 2025 | -0.1894 |
| June 30, 2025 | -0.2187 |
| March 31, 2025 | -0.2488 |
| December 31, 2024 | -0.2298 |
| September 30, 2024 | -0.4199 |
| June 30, 2024 | -0.5109 |
| March 31, 2024 | -0.2303 |
| December 31, 2023 | -0.5263 |
| September 30, 2023 | -0.4475 |
| June 30, 2023 | -0.4643 |
| March 31, 2023 | -0.6269 |
| December 31, 2022 | -0.5208 |
| September 30, 2022 | -0.6393 |
| June 30, 2022 | -0.8752 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.7471 |
| December 31, 2021 | -0.594 |
| September 30, 2021 | -0.5706 |
| June 30, 2021 | -0.5709 |
| March 31, 2021 | -0.5635 |
| December 31, 2020 | -0.5397 |
| September 30, 2020 | -0.5341 |
| June 30, 2020 | -0.5314 |
| March 31, 2020 | -0.633 |
| December 31, 2019 | -0.6551 |
| September 30, 2019 | -0.5895 |
| June 30, 2019 | -0.7034 |
| March 31, 2019 | -0.7006 |
| December 31, 2018 | -0.7353 |
| September 30, 2018 | -0.4101 |
| June 30, 2018 | -0.527 |
| March 31, 2018 | -0.4422 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.5293 |
| AngioDynamics, Inc. | -0.1689 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
| Baxter International, Inc. | 0.2432 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.26M |
| Revenue (Quarterly) | 19.29M |
| Total Expenses (Quarterly) | 30.55M |
| Enterprise Value | 69.45M |
| Gross Profit Margin (Quarterly) | 72.28% |
| Profit Margin (Quarterly) | -58.38% |
| Earnings Yield | -80.30% |
| Normalized Earnings Yield | -79.05 |